Performance of Guideline‐Recommended Approaches to Echocardiographic Investigation for Pulmonary Hypertension: Analysis of the CIPHER Study

Documenti analoghi

• Two prospective, multicenter studies for the identification of biomarker signatures for early detection of pulmonary hypertension (PH): The CIPHER and CIPHER‐MRI studies
  di: Allan Lawrie, et al.
  Pubblicazione: (2024)
• Sotatercept to Wean Off Prostacyclin Infusion Therapy for Pulmonary Arterial Hypertension: A Case Report
  di: Daniel J. Strick, et al.
  Pubblicazione: (2025)
• Relationship Between Phenotypical and Echocardiographic Findings With Pulmonary Hypertension in COPD Patients
  di: Sayyed Gholamreza Mortazavi Moghaddam, et al.
  Pubblicazione: (2025)
• The Pulmonary Hypertension Global Patient Survey: Understanding the Invisible Burden of Paediatric Pulmonary Hypertension
  di: Sadia Quyam, et al.
  Pubblicazione: (2026)
• Comorbidities and Events of Clinical Interest in Patients with Pulmonary Arterial Hypertension (PAH): Analysis of Real‐World Data
  di: Julia R. DiBello, et al.
  Pubblicazione: (2026)